BioMarin to Discuss FDA Approval of VIMIZIM(TM) and Provide Preliminary 2013 Results

[GlobeNewswire] – – Company to Host Conference Call and Webcast, Tuesday, February 18 at 8:00 a.m. ET more

View todays social media effects on BMRN

View the latest stocks trending across Twitter. Click to view dashboard

See who BioMarin is hiring next, click here to view